Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Antibiotic Trials For COPD May Hinge On Patient-Reported Outcomes, FDA Says

Executive Summary

Outcomes that are clinically important to patients should be the focus of clinical trials for antibiotics to treat acute bacterial exacerbation of chronic bronchitis in patients with chronic obstructive pulmonary disease, FDA recommends in a 1draft guidance released Aug. 21

You may also be interested in...

Industry Collaboration Targets Patient-Reported Outcomes Tools In Cancer

Industry efforts to collaborate on drug development issues have moved into the arena of patient-reported outcomes, with a consortium forming to improve ways patients report cancer-related fatigue

Antimicrobial Placebo-Control Trial Should Be Required By FDA – PhRMA

Antimicrobial drug sponsors would be willing to conduct placebo-controlled trials in acute exacerbation of chronic bronchitis if FDA required such studies, Bristol-Myers Squibb VP-Infectious Disease & Clinical Development Roger Echols, MD, said

Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says

Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts